Tetrandrine as a calcium antagonist

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 8, 1996, Pages 751-753

  Takemura, Haruo ^a   Imoto, Kenshi ^a   Ohshika, Hideyo ^b   Wan, Chiu Yin K ^b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Calcium antagonist; Tetrandrine; Ca2+ (i)

Indexed keywords

BOMBESIN; BRADYKININ; CALCIUM CHANNEL BLOCKING AGENT; CARBACHOL; TETRANDRINE; THAPSIGARGIN;

ANIMAL CELL; CALCIUM METABOLISM; CONFERENCE PAPER; DRUG STRUCTURE; FIBROBLAST; NONHUMAN; RAT;

EID: 0029832647     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb01772.x     Document Type: Conference Paper

References (17)

1. King VF, Garcia ML, Himmel D et al. Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin. J. Biol. Chem. 1988; 263: 2238-44.
2. ++ antagonist: Effects and mechanisms of action in vascular smooth muscle cells. J. Pharmacol. Exp. Ther. 1995; 273: 32-9.
3. Liu QY, Karpinski E, Rao MR, Pang PKT. Tetrandrine: A novel calcium channel antagonist inhibits type I calcium channels in neuroblastoma cells. Neuropharmacology 1991; 30: 1325-31.
4. Rossier MF, Python CP, Capponi AM, Schlegel W, Kwan CY, Vallotton MB. Blocking T-type calcium channels with tetrandrine inhibits steroidogenesis in bovine adrenal glomerulosa cells. Endocrinology 1993; 132: 1035-43.
5. Liu QY, Karpinski E, Pang PKT. Tetrandrine inhibits both T and L calcium channel currents in ventricular cells. J. Cardiovasc. Pharmacol 1992; 20: 513-19.
6. Weinsberg F, Bickmeyer U, Wiegand H. Effects of tetrandrine on calcium channel currents of bovine chromaffin cells. Neuropharmacology 1994; 33: 885-90.
7. Kwan CY, Deng HW, Guan YY. Tetrandrine is not a selective calcium channel blocker in vascular smooth muscle. Ada Pharmacol. Sin. 1992; 13: 385-90.
8. Leung YM, Kwan CY, Loh TT. Dual effects of tetrandrine on cytosolic calcium in human leukaemic HL-60 cells: Intracellular calcium release and calcium entry blockade. Br. J. Pharmacol. 1994; 113: 767-74.
9. Takemura H, Kwan CY, Ohshika H. Effects of tetrandrine on calcium entry in various types of cells. Res. Commun. Mol. Pathol Pharmacol. 1995; 90: 59-68.
10. Putney JW Jr. A model for receptor-regulated calcium entry. Cell Calcium 1986; 7:1-12.
11. Putney J W Jr, Bird GS J. The inositol phosphate-calcium signaling system in nonexcitable cells. Endocr. Rev. 1993; 14: 610-31.
12. Takemura H, Hughes AR, Thastrup O, Putney JW Jr. Activation of calcium entry by the tumor promoter, thapsigargin, in parotid acinar cells. Evidence that an intracellular calcium pool, and not an inositol phosphate, regulates calcium fluxes at the plasma membrane. J. Biol. Chem. 1989; 264: 12266-71.
13. loannoni B, Chalmers AH, Seow WK, McCormack JG, Thong YH. Tetrandrine and transmembrane signal transduction: Effect on phosphoinositide metabolism, calcium flux and protein kinase C translocation in human lymphocytes. Int. Arch. Allergy Appl. Immunol. 1989; 89: 349-54.
14. Seow WK, Li SY, Thong YH. Inhibitory effects of tetrandrine on human neutrophil and monocyte adherence. Immunol. Lett. 1986; 13: 83-8.
15. Ferrante A, Seow WK, Rowan-Kelly B, Thong YH. Tetrandrine, a plant alkaloid, inhibits the production of tumour necrosis factoralpha (cachectin) by human monocytes. Clin. Exp. Immunol. 1990; 80: 232-5.
16. Wiegand H, Meis S, Gotzsch U. Inhibition by tetrandrine of calcium currents at mouse motor nerve endings. Brain Res. 1990; 524:112-18.
17. Wang G, Lemos JR. Tetrandrine blocks a slow, large-conductance, Ca2-activated potassium channel besides inhibiting a non-inactivating Ca2-current in isolated nerve terminals of the rat neurohypophysis. Pflugers Arch. 1992; 421: 558-65.